Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
The Effect of Maximal Strength Training on Lung Function in Patients With COPD
The purpose of this study is to investigate the effect on maximal strength training on muscle function, lung function and quality of life for patients diagnosed with COPD grade II-III (Gold scale). Each patient will complete a total of 20 exercise session participating in a rehabilitation program for 4 weeks. Physiological and functional testing will be performed 4 weeks before the training intervention, at baseline and after the intervention period.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - COPD-diagnosis grade II-III (Gold Classification) - Patients in one of two rehabilitation centres in Trondheim, Norway. - Must be able to perform the test procedures walking or running on a treadmill. - Must participate in at least 18 of the 20 planned training sessions. Exclusion Criteria: - Other pulmonary disease than COPD - Diabetes mellitus or other metabolic diseases - Use of corticosteroids the last 6 weeks - Pulmonary infection the last 4 weeks |
Country | Name | City | State |
---|---|---|---|
Norway | My Workout - Medical Rehabilitation Clinic | Trondheim |
Lead Sponsor | Collaborator |
---|---|
Molde University College |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Maximal Strenght | Measured in 1 repetition maximum (kg) in leg press. | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Rate of Force Development | Measured in Newton using a force plate | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Forced Expiratory Volume (FEV1) | Measured using spirometry as the maximal volume of air (liter) exhaled in the first second of expiration | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Peak Expiratory Flow (PEF) | Measured using spirometry as the maximal speed of expiration (Measured as liter/min) | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Work Economy | Measured using CPET walking on a treadmill at a standardized speed and incline (Measured as VO2 ml/kg/min) | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Maximal Oxygen Consumption | Measured using CPET in maximal test walking until exhaustion(Measured as VO2 ml/kg/min) | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Stair Climbing-test | Measured in seconds as the average of two attempts | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in Timed up and Go-test | Measured in seconds as the average of two attempts | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Primary | Change in 6 Minutes Walk Test | Measured in meters | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Secondary | Changes in health-related quality of life - Norwegian RAND36 | Questionnaire scoring on a 0-100 scale with higher scores identifying better outcomes | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Secondary | Changes in health-related quality of life - Hospital and Anxiety Score (HADS) | Questionnaires - Change in total score from 0-21 where higher score may indicate anxiety and/or depression | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Secondary | Changes in health-related quality of life - International physical activity questionnaire (IPAQ) | Questionnaires - Change in MET-minutes of physical acitivity a week with higher score identifying better outcomes | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Secondary | Changes in health-related quality of life - EQ-5D-5L | Questionnaires - Change in health state from level 1-5 with lower level identifying better outcomes | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. | |
Secondary | Changes in health-related quality of life - Visual Analogue Scale (VAS) | Questionnaires - Units on a Scale from 0-10 cm with lower score identifying better outcomes | 4 weeks before the intervention, at baseline and after 20 training sessions during 4 weeks weeks of rehabilitation. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|